Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 14/20 | 0.48 |
| ▸ | CTSG | P08311 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | PEPD | P12955 | 1/20 | 0.44 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18621031 | 1.00 | PREP (0.52) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL22209505 | 0.91 | CCR1 (0.54) | PREPTAAR1ELANECCR1 | |
| SCHEMBL18621674 | 0.91 | CCR1 (0.54) | PREPTAAR1ELANECCR1 | |
| SCHEMBL18621640 | 0.89 | PREP (0.52) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL18619671 | 0.89 | LMNA (0.53) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL22209430 | 0.89 | LMNA (0.53) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL22209498 | 0.89 | PREP (0.52) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL18621029 | 0.89 | CCR1 (0.53) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL22209512 | 0.89 | CCR1 (0.53) | PREPTAAR1ELANECTSGACE | |
| SCHEMBL20484538 | 0.89 | PREP (0.53) | PREPTAAR1ELANECTSGACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10711036-B2 | MALT1 inhibitors and uses thereof | CORNELL UNIVERSITY (US) | 2020-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711036-B2 | MALT1 inhibitors and uses thereof | MALT1, BCL3, BCL6 | PREP 1162/4885TAAR1 4584/4885ELANE 2951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.